111 related articles for article (PubMed ID: 18625351)
1. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification.
Bai Y; Wang MY; Han YH; Dou SW; Lin Q; Guo Y; Li W; Ding DG; Dai JP; Qin W; Shi DP; Tian J; Dai YM
PLoS One; 2013; 8(1):e53237. PubMed ID: 23308170
[TBL] [Abstract][Full Text] [Related]
3. Prostate MRI: access to and current practice of prostate MRI in the United States.
Leake JL; Hardman R; Ojili V; Thompson I; Shanbhogue A; Hernandez J; Barentsz J
J Am Coll Radiol; 2014 Feb; 11(2):156-60. PubMed ID: 24389134
[TBL] [Abstract][Full Text] [Related]
4. Case report: Prostatic malakoplakia: a rare disease that has a profile mimicking prostate cancer.
Ren Y; Chen W; Zhang M; Zhang X; Zhou J; Li Y; Cai D
Front Oncol; 2024; 14():1348797. PubMed ID: 38665958
[TBL] [Abstract][Full Text] [Related]
5. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
Lawrentschuk N; Fleshner N
BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer.
Ingole SM; Mehta RU; Kazi ZN; Bhuyar RV
Indian J Radiol Imaging; 2021 Jan; 31(1):65-77. PubMed ID: 34316113
[No Abstract] [Full Text] [Related]
7. A systematic review on multiparametric MR imaging in prostate cancer detection.
Fusco R; Sansone M; Granata V; Setola SV; Petrillo A
Infect Agent Cancer; 2017; 12():57. PubMed ID: 29093748
[TBL] [Abstract][Full Text] [Related]
8. Differentiation Diagnosis of Hypo-Intense T2 Area in Unilateral Peripheral Zone of Prostate Using Magnetic Resonance Spectroscopy (MRS): Prostate Carcinoma versus Prostatitis.
Zhang TH; Hu CH; Chen JX; Xu ZD; Shen JK
Med Sci Monit; 2017 Aug; 23():3837-3843. PubMed ID: 28790299
[TBL] [Abstract][Full Text] [Related]
9. Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers.
Nicolae AM; Venugopal N; Ravi A
Cancer Nanotechnol; 2016; 7(1):6. PubMed ID: 27441041
[TBL] [Abstract][Full Text] [Related]
10. Focal therapy for prostate cancer: The current status.
Marshall S; Taneja S
Prostate Int; 2015 Jun; 3(2):35-41. PubMed ID: 26157765
[TBL] [Abstract][Full Text] [Related]
11. The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen.
Cho HJ; Shin SC; Cho JM; Kang JY; Yoo TK
Prostate Int; 2014 Dec; 2(4):196-202. PubMed ID: 25599076
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
[TBL] [Abstract][Full Text] [Related]
13. Innovations in diagnostic imaging of localized prostate cancer.
Pummer K; Rieken M; Augustin H; Gutschi T; Shariat SF
World J Urol; 2014 Aug; 32(4):881-90. PubMed ID: 24078105
[TBL] [Abstract][Full Text] [Related]
14. MRI-targeted prostate biopsy: a review of technique and results.
Robertson NL; Emberton M; Moore CM
Nat Rev Urol; 2013 Oct; 10(10):589-97. PubMed ID: 24061532
[TBL] [Abstract][Full Text] [Related]
15. Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.
Nelson AW; Harvey RC; Parker RA; Kastner C; Doble A; Gnanapragasam VJ
PLoS One; 2013; 8(2):e57480. PubMed ID: 23460864
[TBL] [Abstract][Full Text] [Related]
16. Integrating multiparametric prostate MRI into clinical practice.
Padhani AR
Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S27-37. PubMed ID: 22187067
[TBL] [Abstract][Full Text] [Related]
17. [Diagnose importance of multiparametric magnetic resonance tomography for prostate cancer].
Fueger BJ; Helbich TH; Schernthaner M; Zbýn S; Linhart HG; Stiglbauer A; Doan A; Pinker K; Heinz G; Padhani AR; Brader P
Radiologe; 2011 Nov; 51(11):947-54. PubMed ID: 21976041
[TBL] [Abstract][Full Text] [Related]
18. MRI of localized prostate cancer: coming of age in the PSA era.
Türkbey B; Bernardo M; Merino MJ; Wood BJ; Pinto PA; Choyke PL
Diagn Interv Radiol; 2012; 18(1):34-45. PubMed ID: 21922459
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in magnetic resonance imaging of prostate cancer.
Lawrentschuk N; Lindner U
F1000 Med Rep; 2010 Dec; 2():86. PubMed ID: 21283654
[TBL] [Abstract][Full Text] [Related]
20. MRI for men undergoing active surveillance or with rising PSA and negative biopsies.
Raz O; Haider M; Trachtenberg J; Leibovici D; Lawrentschuk N
Nat Rev Urol; 2010 Oct; 7(10):543-51. PubMed ID: 20930867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
